RSCM

Rock Springs Capital Management Portfolio holdings

AUM $1.71B
1-Year Est. Return 43.68%
This Quarter Est. Return
1 Year Est. Return
+43.68%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.12B
AUM Growth
-$643M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
150
New
Increased
Reduced
Closed

Top Buys

1
+$36.4M
2
+$19.4M
3
+$11.5M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$10.3M
5
RARE icon
Ultragenyx Pharmaceutical
RARE
+$9.78M

Top Sells

1
+$30.7M
2
+$23.6M
3
+$17.3M
4
ECYT
Endocyte, Inc. Common Stock
ECYT
+$15.1M
5
ELAN icon
Elanco Animal Health
ELAN
+$13.1M

Sector Composition

1 Healthcare 88.36%
2 Consumer Staples 0.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
101
$4.46M 0.21%
3,474
-579
102
$4.42M 0.21%
400,000
-75,000
103
$4.31M 0.2%
750,000
104
$4.08M 0.19%
40,000
105
$3.72M 0.18%
517,000
-83,000
106
$3.7M 0.17%
2,325,000
-75,000
107
$3.58M 0.17%
2,000,000
-525,557
108
$3.48M 0.16%
380,000
+112,000
109
$3.45M 0.16%
57,143
110
$3.23M 0.15%
275,000
-70,000
111
$3.23M 0.15%
525,000
112
$2.99M 0.14%
1,200,000
113
$2.61M 0.12%
277,236
-4,564
114
$2.58M 0.12%
+835,000
115
$2.39M 0.11%
1,100,000
+21,835
116
$2.34M 0.11%
6,400
-800
117
$2.31M 0.11%
450,000
118
$1.93M 0.09%
150,000
119
$1.92M 0.09%
100,000
-133,073
120
$1.63M 0.08%
525,000
121
$1.58M 0.07%
3,933
-2,400
122
$1.47M 0.07%
400,000
-175,000
123
$1.3M 0.06%
+2,857
124
$1.03M 0.05%
80,981
-194,019
125
– –
-325,000
2 3 4
5
6